Proto Labs Inc Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| (in thousands, except share and per share amounts) | 2025 | 2024 | 2023 | ||||||||||||||
| Net income | $ | 21,241 | $ | 16,593 | $ | 17,220 | |||||||||||
| Basic - weighted-average shares outstanding: | 23,922,703 | 25,096,117 | 26,186,533 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Employee stock options and other | 322,496 | 116,061 | 36,965 | ||||||||||||||
| Diluted - weighted-average shares outstanding: | 24,245,199 | 25,212,178 | 26,223,498 | ||||||||||||||
| Net income per share attributable to common shareholders: | |||||||||||||||||
| Basic | $ | 0.89 | $ | 0.66 | $ | 0.66 | |||||||||||
| Diluted | $ | 0.88 | $ | 0.66 | $ | 0.66 | |||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.